AS2-1相关论文
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with High-Grade Glioma. Final Report (
Standard treatment for high-grade glioma involves surgical resection followed by radiation therapy and temozolomide. Unf......
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Recurrent, Refractory or Progress
Primary malignant brain tumors are a leading cause of cancer-related death in children. This Phase II study evaluated th......
Recurrent GBM (RGBM) has a highly unfavorable prognosis with majority of patients dying within 6 months and no standard ......
A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Recurrent Glioblastoma Mult
Treatment of recurrent glioblastoma multiforme (RGBM) creates one of the most difficult challenges to neuro-oncology. Th......
Antineoplastons A10 and AS2-1 (ANP) are synthetic derivatives of glutamine, isoglutamine, and phenylacetic acid. In 1993......
Inoperable brainstem gliomas (BSG) are among the most difficult to treat malignancies. In the intent-to-treat (ITT) popu......
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Proto
Despite dramatic progress over the last 50 years in the treatment of many childhood cancers, primary brain tumors remain......